-
1by El Nasasra, Aref Beigel, Roy Klempfner, Robert Alnsasra, Hilmi Matetzky, Shlomi Iakobishvili, Zaza Rubinshtein, Ronen Halabi, Majdi Blatt, Alex Zahger, Doron Published in The American journal of cardiology (15.03.2021)“...The contemporary benefit of routine beta-blocker therapy following myocardial infraction in the absence of heart failure or left ventricular systolic...”
-
2by O’Donoghue, Michelle L Glaser, Ruchira Cavender, Matthew A Aylward, Philip E Bonaca, Marc P Budaj, Andrzej Davies, Richard Y Dellborg, Mikael Fox, Keith A. A Gutierrez, Jorge Antonio T Hamm, Christian Kiss, Robert G Kovar, František Kuder, Julia F Im, Kyung Ah Lepore, John J Lopez-Sendon, Jose L Ophuis, Ton Oude Parkhomenko, Alexandr Shannon, Jennifer B Spinar, Jindrich Tanguay, Jean-Francois Ruda, Mikhail Steg, P. Gabriel Theroux, Pierre Wiviott, Stephen D Laws, Ian Sabatine, Marc S Morrow, David A Published in JAMA : the journal of the American Medical Association (19.04.2016)“...IMPORTANCE: p38 Mitogen-activated protein kinase (MAPK)–stimulated inflammation is implicated in atherogenesis, plaque destabilization, and maladaptive...”
-
3by Naber, Christoph K Urban, Philip Ong, Paul J Valdes-Chavarri, Mariano Abizaid, Alexandre A Pocock, Stuart J Fabbiocchi, Franco Dubois, Christophe Copt, Samuel Greene, Samantha Morice, Marie-Claude Published in European heart journal (01.04.2017)“...Although a true clinical challenge, high bleeding risk patients with an acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) have...”
-
4by Collins, Rory, Prof Reith, Christina, FRCP (Glasg.) Emberson, Jonathan, PhD Armitage, Jane, Prof Baigent, Colin, Prof Blackwell, Lisa, BSc Blumenthal, Roger, Prof Danesh, John, Prof Smith, George Davey, Prof DeMets, David, Prof Evans, Stephen, Prof Law, Malcolm, Prof MacMahon, Stephen, Prof Martin, Seth, MD Neal, Bruce, Prof Poulter, Neil, Prof Preiss, David, PhD Ridker, Paul, Prof Roberts, Ian, Prof Rodgers, Anthony, Prof Sandercock, Peter, Prof Schulz, Kenneth, Prof Sever, Peter, Prof Simes, John, Prof Smeeth, Liam, Prof Wald, Nicholas, Prof Yusuf, Salim, Prof Peto, Richard, Prof Published in The Lancet (British edition) (2016)“...Summary This Review is intended to help clinicians, patients, and the public make informed decisions about statin therapy for the prevention of heart attacks...”
-
5by Ridker, Paul M MacFadyen, Jean G Everett, Brendan M Libby, Peter Thuren, Tom Glynn, Robert J Ridker, Paul M MacFadyen, Jean G Everett, Brendan M Libby, Peter Thuren, Tom Glynn, Robert J Kastelein, John Koenig, Wolfgang Genest, Jacques Lorenzatti, Alberto Varigos, John Siostrzonek, Peter Sinnaeve, Peter Fonseca, Francisco Nicolau, Jose Gotcheva, Nina Yong, Huo Urina-Triana, Miguel Milicic, Davor Cifkova, Renata Vettus, Riina Anker, Stephan D Manolis, Athanasios J Wyss, Fernando Forster, Tamas Sigurdsson, Axel Pais, Prem Fucili, Alessandro Ogawa, Hisao Shimokawa, Hiroaki Veze, Irina Petrauskiene, Birute Salvador, Leon Cornel, Jan Hein Klemsdal, Tor Ole Medina, Felix Budaj, Andrzej Vida-Simiti, Luminita Kobalava, Zhanna Otasevic, Petar Pella, Daniel Lainscak, Mitja Seung, Ki-Bae Commerford, Patrick Dellborg, Mikael Donath, Marc Hwang, Juey-Jen Kultursay, Hakan Flather, Marcus Ballantyne, Christie Bilazarian, Seth Chang, William East, Cara Forgosh, Les Harris, Barry Ligueros, Monica Published in The Lancet (British edition) (27.01.2018)“...Canakinumab, a monoclonal antibody targeting interleukin-1β, reduces inflammation and cardiovascular event rates with no effect on lipid concentrations...”
-
6by Reed, Grant W, MD Rossi, Jeffrey E, MD Cannon, Christopher P, Prof Published in The Lancet (British edition) (2016)“...Summary Acute myocardial infarction has traditionally been divided into ST elevation or non-ST elevation myocardial infarction; however, therapies are similar...”
-
7by Puymirat, Etienne Lamhaut, Lionel Bonnet, Nicolas Aissaoui, Nadia Henry, Patrick Cayla, Guillaume Cattan, Simon Steg, Gabriel Mock, Laurent Ducrocq, Gregory Goldstein, Patrick Schiele, François Bonnefoy-Cudraz, Eric Simon, Tabassome Danchin, Nicolas Published in European heart journal (01.04.2016)“...The use of opioids is recommended for pain relief in patients with myocardial infarction (MI) but may delay antiplatelet agent absorption, potentially leading...”
-
8by Tardif, Jean-Claude Kouz, Simon Waters, David D Bertrand, Olivier F Diaz, Rafael Maggioni, Aldo P Pinto, Fausto J Ibrahim, Reda Gamra, Habib Kiwan, Ghassan S Berry, Colin López-Sendón, José Ostadal, Petr Koenig, Wolfgang Angoulvant, Denis Grégoire, Jean C Lavoie, Marc-André Dubé, Marie-Pierre Rhainds, David Provencher, Mylène Blondeau, Lucie Orfanos, Andreas L’Allier, Philippe L Guertin, Marie-Claude Roubille, François Published in The New England journal of medicine (26.12.2019)“...Inflammation appears to play a role in atherosclerosis, raising the possibility that treatments that reduce inflammation could prevent cardiovascular events...”
-
9by Parodi, Guido Xanthopoulou, Ioanna Bellandi, Benedetta Gkizas, Vassilios Valenti, Renato Karanikas, Stavros Migliorini, Angela Angelidis, Christos Abbate, Rosanna Patsilinakos, Sotirios Baldereschi, Giorgio J Marcucci, Rossella Gensini, Gian Franco Antoniucci, David Alexopoulos, Dimitrios Published in Journal of the American College of Cardiology (10.02.2015)
-
10by Scherillo, Marino Cirillo, Plinio Formigli, Dario Bonzani, Giulio Calabrò, Paolo Capogrosso, Paolo Farina, Rosario Lanzillo, Tonino Mascia, Franco Mauro, Ciro Tuccillo, Bernardino Bellis, Alessandro Bianchi, Renato Cimmino, Giovanni Piro, Orlando Ravera, Amelia Scotto di Uccio, Fortunato Tammaro, Paolo Vetrano, Alfredo Trimarco, Bruno Published in Angiology (01.08.2017)“...The incidence of ST-segment elevation myocardial infarction (STEMI) has significantly decreased. Conversely, the rate of non-STEMI (NSTEMI) has increased...”
-
11by Ridker, Paul M Everett, Brendan M Thuren, Tom MacFadyen, Jean G Chang, William H Ballantyne, Christie Fonseca, Francisco Nicolau, Jose Koenig, Wolfgang Anker, Stefan D Kastelein, John J.P Cornel, Jan H Pais, Prem Pella, Daniel Genest, Jacques Cifkova, Renata Lorenzatti, Alberto Forster, Tamas Kobalava, Zhanna Vida-Simiti, Luminita Flather, Marcus Shimokawa, Hiroaki Ogawa, Hisao Dellborg, Mikael Rossi, Paulo R.F Troquay, Roland P.T Libby, Peter Glynn, Robert J Published in The New England journal of medicine (21.09.2017)“...Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The...”
-
12by Ridker, Paul M Everett, Brendan M Pradhan, Aruna MacFadyen, Jean G Solomon, Daniel H Zaharris, Elaine Mam, Virak Hasan, Ahmed Rosenberg, Yves Iturriaga, Erin Gupta, Milan Tsigoulis, Michelle Verma, Subodh Clearfield, Michael Libby, Peter Goldhaber, Samuel Z Seagle, Roger Ofori, Cyril Saklayen, Mohammad Butman, Samuel Singh, Narendra Le May, Michel Bertrand, Olivier Johnston, James Paynter, Nina P Glynn, Robert J Published in The New England journal of medicine (21.02.2019)“...Patients with coronary artery disease were randomly assigned to either methotrexate (15 to 20 mg weekly) or placebo. At a median of 2.3 years, there was no...”
-
13by Makam, Raghavendra Charan P., MD, MPH Erskine, Nathaniel, BS McManus, David D., MD Lessard, Darleen, MS Gore, Joel M., MD Yarzebski, Jorge, MD, MPH Goldberg, Robert J., PhD Published in The American journal of cardiology (2016)“...Abstract Optimization of medical therapy during discharge planning is vital for improving patient outcomes after hospitalization for acute myocardial...”
-
14by Bonaca, Marc P Bhatt, Deepak L Cohen, Marc Steg, Philippe Gabriel Storey, Robert F Jensen, Eva C Magnani, Giulia Bansilal, Sameer Fish, M. Polly Im, Kyungah Bengtsson, Olof Ophuis, Ton Oude Budaj, Andrzej Theroux, Pierre Ruda, Mikhail Hamm, Christian Goto, Shinya Spinar, Jindrich Nicolau, José Carlos Kiss, Robert G Murphy, Sabina A Wiviott, Stephen D Held, Peter Braunwald, Eugene Sabatine, Marc S Published in The New England journal of medicine (07.05.2015)“...Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose...”
-
15by Austin, Peter C Published in Statistics in medicine (30.03.2014)“...Propensity score methods are increasingly being used to estimate causal treatment effects in observational studies. In medical and epidemiological studies,...”
-
16by Kim, Yong Hoon Her, Ae-Young Jeong, Myung Ho Kim, Byeong-Keuk Lee, Seung-Yul Hong, Sung-Jin Shin, Dong-Ho Kim, Jung-Sun Ko, Young-Guk Choi, Donghoon Hong, Myeong-Ki Jang, Yangsoo Published in Atherosclerosis (01.01.2019)“...We compared the clinical impact of renin-angiotensin system inhibitors (RASI) on long-term clinical outcomes between ST-segment elevation (STEMI) and...”
-
17by Mehta, Shamir R Wood, David A Storey, Robert F Mehran, Roxana Bainey, Kevin R Nguyen, Helen Meeks, Brandi Di Pasquale, Giuseppe López-Sendón, Jose Faxon, David P Mauri, Laura Rao, Sunil V Feldman, Laurent Steg, P. Gabriel Avezum, Álvaro Sheth, Tej Pinilla-Echeverri, Natalia Moreno, Raul Campo, Gianluca Wrigley, Benjamin Kedev, Sasko Sutton, Andrew Oliver, Richard Rodés-Cabau, Josep Stanković, Goran Welsh, Robert Lavi, Shahar Cantor, Warren J Wang, Jia Nakamya, Juliet Bangdiwala, Shrikant I Cairns, John A Published in The New England journal of medicine (10.10.2019)“...Patients with ST-segment elevation MI and multivessel coronary disease who had undergone successful culprit-lesion PCI were assigned to a strategy of either...”
-
18
-
19by Purcell, Brendan P Lobb, David Charati, Manoj B Dorsey, Shauna M Wade, Ryan J Zellars, Kia N Doviak, Heather Pettaway, Sara Logdon, Christina B Shuman, James A Freels, Parker D Gorman, 3rd, Joseph H Gorman, Robert C Spinale, Francis G Burdick, Jason A Published in Nature materials (01.06.2014)“...Inhibitors of matrix metalloproteinases (MMPs) have been extensively explored to treat pathologies where excessive MMP activity contributes to adverse tissue...”
-
20by Austin, Peter C Published in Statistics in medicine (15.03.2014)“...Propensity‐score matching is increasingly being used to reduce the confounding that can occur in observational studies examining the effects of treatments or...”